Hostility of drug-free patients with schizophrenia and n− 3 polyunsaturated fatty acid levels in red blood cells

M Watari, K Hamazaki, T Hirata, T Hamazaki… - Psychiatry …, 2010 - Elsevier
Many reports suggest that n− 3 polyunsaturated fatty acids (PUFAs) influence the symptoms
of psychiatric disorders. Moreover, it has also been reported that n− 3 PUFAs control …

Drug therapies for tardive dyskinesia: part 2

RH Howland - Journal of Psychosocial Nursing and Mental …, 2011 - journals.healio.com
Tardive dyskinesia (TD) is a serious complication associated with the long-term use of
dopamine receptor-blocking drugs. No drugs are approved by the US Food and Drug …

Impacts of Omega-3 Fatty Acids, Natural Elixirs for Neuronal Health, on Brain Development and Functions

AS Rao, A Nair, K Nivetha, B Ayesha, K Hardi… - … : Method and Protocols, 2024 - Springer
Omega-3 fatty acids play a seminal role in maintaining the structural and functional integrity
of the nervous system. These specialized molecules function as precursors for many lipid …

The use of omega-3 fatty acids in mental illness

JL Gören, AT Tewksbury - Journal of pharmacy practice, 2011 - journals.sagepub.com
Purpose: This article will summarize the current evidence on the effects of omega-3 fatty
acids on prevention and treatment of mental illness. Background: Omega-3 fatty acids are …

Mechanisms of involvement of eicosanoids and their precursors in the pathophysiology and treatment of schizophrenia

L Schmidt, U Ceglarek, L Kortz, M Hoop… - Medicinal …, 2013 - ingentaconnect.com
The pathophysiology of schizophrenia has not been fully elucidated but there are
converging leads to understanding this complex psychiatric disorder. One family of …

Increased PLA2 activity in individuals at ultra-high risk for psychosis

LL Talib, AC Costa, HPG Joaquim, CAC Pereira… - European archives of …, 2021 - Springer
Phospholipase A 2 is the main enzyme in the metabolism of membrane phospholipids. It
comprises a family of enzymes divided into iPLA 2, cPLA 2 and sPLA 2. Studies have …

[PDF][PDF] Natural medicines in schizophrenia: a systematic review

R Hoenders, A Bartels-Velthuis, N Vollbehr… - J Altern Complement …, 2014 - Citeseer
Conclusion: High-quality research on natural medicines for schizophrenia is scarce.
However, there is emerging evidence for improved outcome for glycine, sarcosine, NAC …

The role of omega-3 polyunsaturated fatty acids in mental disorders

KW Lange, Y Nakamura - Movement and Nutrition in Health …, 2020 - movement-nutrition.de
While the role of omega-3 polyunsaturated fatty acids (PUFAs) in physical health is well
established, it is becoming increasingly evident that they are also important for mental …

Neurobiological meaning of omega-3 fatty acids and their potential role in the treatment of schizophrenia

M Mazza, G Marano, G Traversi, S Mazza… - Omega Fatty Acids in …, 2019 - Elsevier
Schizophrenia is a major mental disorder characterized by hallucinations, delirium,
behavioral disorders, and a variable range of chronic persistent symptoms. The mainstay in …

Immunologische behandlungsoptionen bei schizophrenen störungen

N Müller, D Krause, E Weidinger… - Fortschritte der …, 2014 - thieme-connect.com
Der pathophysiologische Mechanismus, der bei Schizophrenie zur dopaminergen
Dysfunktion führt, ist nach wie vor unklar. Ein entzündliches Geschehen scheint dabei eine …